Panacea Biotec said it will collaborate with Refana Inc for COVID vaccine (Representational)
Bengaluru: Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.
Panacea’s shares jumped 20% in morning trading on the National Stock Exchange after the news.
About Post Author
